The impact of ethnicity on response to antihypertensive therapy (Q41171801)

27 September 2017

1 reference

title

The impact of ethnicity on response to antihypertensive therapy (English)

1 reference

27 September 2017

K Jamerson

1

1 reference

PubMed ID

8876472

27 September 2017

V DeQuattro

series ordinal

2

1 reference

PubMed ID

8876472

27 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

American Journal of Medicine

27 September 2017

1 reference

27 September 2017

101

1 reference

27 September 2017

22S-32S

1 reference

27 September 2017

3A

1 reference

Impact of race on treatment response and cardiovascular disease among hypertensives.

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Socio-Ecological Stress, Suppressed Hostility, Skin Color, and Black-White Male Blood Pressure: Detroit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

The association of skin color with blood pressure in US blacks with low socioeconomic status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

John Henryism and blood pressure differences among black men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Excess mortality in Harlem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

The value of aggressive therapy in the hypertensive patient with azotemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

CHANGES IN RENAL FUNCTION ASSOCIATED WITH DRUG OR PLACEBO THERAPY OF HUMAN HYPERTENSION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Renal insufficiency in treated essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

An epidemiological study of left ventricular hypertrophy in the biracial population of Evans County, Georgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Electrocardiographic estimate of left ventricular mass versus radiographic cardiac size and the risk of cardiovascular disease mortality in the epidemiologic follow-up study of the First National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Left ventricular hypertrophy in black and white hypertensives. Standard electrocardiographic criteria overestimate racial differences in prevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Hypertension, cardiac disease, and compliance in minority patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Mortality by Hispanic status in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Changes in lipid and lipoprotein levels and body weight in Tarahumara Indians after consumption of an affluent diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Hypertension in the Hispanic-American population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Hypertension in Hispanics. Comments on a major disease in a mix of ethnic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Suboptimal outcome of management of metabolic cardiovascular risk factors in Hispanic patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Racial differences in the relation between blood pressure and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Evidence of bimodality of two hour plasma glucose concentrations in Mexican Americans: results from the San Antonio Heart study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Plasma insulin response among Nauruans. Prediction of deterioration in glucose tolerance over 6 yr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Cardiovascular risk factors among Asian Americans living in northern California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Blood pressure in youth from four ethnic groups: the Pasadena Prevention Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: blood pressure distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Ineffectiveness of propranolol in hypertensive Jamaicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Racial differences in pressure, volume and renin interrelationships in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Impact of age, race, and obesity on hypertensive mechanisms and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Antihypertensive treatment according to age, plasma renin and race

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Can renal failure due to hypertension be prevented?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Socioeconomic status in the epidemiology and treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Racial differences in antihypertensive therapy: evidence and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Prazosin versus hydrochlorothiazide as initial antihypertensive therapy in black versus white patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Antihypertensive response to ketanserin: influence of race and weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Glucose and cholesterol elevations during thiazide therapy: intention-to-treat versus actual on-therapy experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Antihypertensive Drug Therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

A delayed answer to the calcium blocker question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

Immigration, stress, and depressive symptoms in a Mexican-American community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900265-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(96)00265-3

1 reference

27 September 2017

1 reference

PubMed ID

8876472